COVID-19 information
/
For the latest updates, please visit our coronavirus (COVID-19) website:
Last updated:

Free COVID-19 at-home test kits

At-home rapid tests are an important strategy to protect your friends and family from getting exposed. Help us stop the spread of COVID-19 in Boston.

iHealth at home Covid test

Update: On March 29, 2022, the FDA granted a three month shelf life extension for the iHealth COVID-19 Antigen Rapid Test. This extends the shelf-life of all iHealth tests with expiration dates on or before 2022-09-29 (YYYY-MM-DD) from 6 months to 9 months. 

Test kits are not currently available at pickup sites in the community, though some community partners are still distributing test kits to priority populations. We will provide more information on this website if additional tests become available.

If you test positive, call your healthcare provider immediately to see if you are eligible for COVID-19 treatment. Follow their
instructions, and keep them informed of your symptoms. If you have questions, please contact the Mayor’s Health Line at 617-534-5050.

Community Distribution Partnership

COVID-19 at home test kits are available for Boston service providers and community partners for distribution to Boston residents. Service providers and partners who request kits must have a focus on communities and populations:

  1. experiencing higher rates of COVID-19, and
  2. barriers to testing. This includes the very real cost barriers to buying these kits.

These kits are intended for distribution to Boston residents.

Supplies are limited. We give priority to organizations that address race and place-based inequities in COVID-19 spread and testing access in a way that is culturally and linguistically competent. Our goal is to connect test kits to high-need communities and vulnerable populations.

Request form for service Providers


Thank you to all of our partners that worked to get these test kits into the hands of residents who need them the most. You've helped us address place-based inequities in COVID-19 spread and testing access.

Back to top